These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2074254)

  • 1. Pharmacokinetics of cefodizime in the elderly following single and repeated intravenous administration of 1 g.
    Nilsen OG; Rennemo F; Rennemo R; Lenfant B
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():71-5. PubMed ID: 2074254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose linearity and other pharmacokinetics of cefodizime after single-dose intravenous administration.
    Dagrosa EE; Hajdú P; Malerczyk V; de Looze S; Seeger K; Grötsch H
    Clin Ther; 1987; 10(1):18-31. PubMed ID: 3450392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of cefodizime administered intravenously as a single-dose (1.0 and 2.0 g) to healthy adult volunteers.
    Bryskier A; Procyk T; Tremblay D; Lenfant B; Fourtillan JB
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():65-70. PubMed ID: 2074253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-dose pharmacokinetics of cefodizime in critically ill elderly patients.
    Meyer B; Traunmueller F; Bojic A; Locker G; Schmid R; Winkler S; Thalhammer F
    Int J Antimicrob Agents; 2006 Apr; 27(4):335-8. PubMed ID: 16563704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics of cefodizime in children.
    Boccazzi A; Fusi G; Mezzopane AM; Maretti M; Careddu P
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():83-7. PubMed ID: 2074256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of cefodizime in patients with various degrees of renal failure.
    Loffreda A; Lampa E; Lucarelli C; Amorena M; Contaldi C; Calderaro V; Rossi F
    Chemotherapy; 1999; 45(1):1-7. PubMed ID: 9876203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of cefodizime following single doses of 0.5, 1.0, 2.0, and 3.0 grams administered intravenously to healthy volunteers.
    Lenfant B; Namour F; Logeais C; Coussediere D; Rivault O; Bryskier A; Surjus A
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2037-41. PubMed ID: 8540712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics of cefodizime following intravenous and intramuscular administration of a single dose of 1.0 g.
    Bryskier A; Procyk T; Tremblay D; Lenfant B; Fourtillan JB
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():59-63. PubMed ID: 2074252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of cefodizime during continuous ambulatory peritoneal dialysis.
    Mendes P; Lameire N; Rosenkranz B; Malerczyk V; Damm D
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():89-93. PubMed ID: 2074257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of cefodizime in elderly patients with moderate or severe renal impairment.
    Veyssier P; Devillers A; Domart Y; Fourtillan JB; Bryskier A; Procyk T
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():77-81. PubMed ID: 2074255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of cefodizime: a review of the data on file.
    Barré J
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():95-101. PubMed ID: 2074258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic profile of cefodizime.
    Brockmeier D; Dagrosa EE
    Infection; 1992; 20 Suppl 1():S14-7. PubMed ID: 1526669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefodizime penetration into skin suction blister fluid following a single intravenous dose.
    Schäfer-Korting M; Korting HC; Maass L; Klesel N; Grigoleit HG; Mutschler E
    Eur J Clin Pharmacol; 1986; 30(3):295-8. PubMed ID: 3732363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NONMEM analysis in determining the tri-exponential disposition of cefotaxime: a method of evaluating serum and urinary phase I data.
    Weber W; Harnisch L; Zimmer M; Rokitta C; Mendes P
    Int J Clin Pharmacol Ther; 1995 Oct; 33(10):560-4. PubMed ID: 8574507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of cefodizime in normal individuals and in patients with renal failure.
    el Guinaidy MA; Nawishy S; Abd el Bary M; Sabbour MS
    Chemotherapy; 1991; 37(2):77-85. PubMed ID: 2032473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosing time and sex-related differences in the pharmacokinetics of cefodizime and in the circadian cortisol rhythm.
    Jonkman JH; Reinberg A; Oosterhuis B; de Noord OE; Kerkhof FA; Motohashi Y; Levi F; Dammacco F; Carandente F
    Chronobiologia; 1988; 15(1-2):89-102. PubMed ID: 3416675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic study of cefodizime and ceftriaxone in sera and bones of patients undergoing hip arthroplasty.
    Scaglione F; De Martini G; Peretto L; Ghezzi R; Baratelli M; Arcidiacono MM; Fraschini F
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2292-4. PubMed ID: 9333066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of cefodizime in volunteers with normal or impaired renal function.
    Conte JE
    J Clin Pharmacol; 1994 Nov; 34(11):1066-70. PubMed ID: 7876397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefodizime in serum and skin blister fluid after single intravenous and intramuscular doses in healthy volunteers.
    Korting HC; Schäfer-Korting M; Maass L; Klesel N; Mutschler E
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1822-5. PubMed ID: 3435129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefodizime and cefotaxime in acute exacerbations of chronic bronchitis: a randomized double-blind prospective study in 180 patients.
    Maesen FP; Davies BI; van den Bergh JJ; Gubbelmans HL; Meek JC; Geraedts WH
    J Antimicrob Chemother; 1990 Mar; 25(3):413-22. PubMed ID: 2187013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.